#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4022840	B	Inhibition of rice alpha-glucosidase assessed as residual activity at 1 mM using 4-Np-alpha-Glc as substrate by UV-visible spectrophotometric method	Oryza sativa	2		assay format	Scientific Literature
2.	ALA4022841	B	Inhibition of wild type C57BL/6 mouse small intestinal sucrase/isomaltase assessed as residual activity at 1 mM using sucrose as substrate after 30 mins	Mus musculus	2		single protein format	Scientific Literature
3.	ALA4022842	B	Inhibition of recombinant human GAA assessed as residual activity at 1 mM using 4-Np-alpha-Glc as substrate by UV-visible spectrophotometric method	Homo sapiens	2		single protein format	Scientific Literature
4.	ALA4022843	B	Inhibition of wild type C57BL/6 mouse small intestinal lactase assessed as residual activity at 1 mM using lactose as substrate after 30 mins	Mus musculus	2		single protein format	Scientific Literature
5.	ALA4022844	B	Inhibition of Pyrococcus furiosus beta-glucosidase assessed as residual activity at 1 mM using 4 Np-beta-Glc as substrate by UV-visible spectrophotometric method	Pyrococcus furiosus	2		assay format	Scientific Literature
6.	ALA4022845	B	Inhibition of Sulfolobus solfataricus P2 beta-glucosidase assessed as residual activity at 1 mM using 4 Np-beta-Glc as substrate by UV-visible spectrophotometric method	Saccharolobus solfataricus	2		assay format	Scientific Literature
7.	ALA4022846	B	Inhibition of GBA1/GBA2 derived from human HL60 cells assessed as residual activity at 1 mM using 4-MU-Glc as substrate after 30 mins by fluorescence assay	Homo sapiens	2		assay format	Scientific Literature
8.	ALA4022847	B	Inhibition of recombinant human GBA1 assessed as residual activity at 1 mM	Homo sapiens	2		single protein format	Scientific Literature
9.	ALA4022848	B	Inhibition of beta-hexosaminidase derived from human HL60 cells assessed as residual activity at 1 mM using 4-MU-GlcNAc as substrate after 30 mins by fluorescence assay	Homo sapiens	2		assay format	Scientific Literature
10.	ALA4022849	B	Inhibition of Thermotoga maritima alpha-galactosidase assessed as residual activity at 1 mM using 4 Np-alpha-Gal as substrate by UV-visible spectrophotometric method	Thermotoga maritima	2		assay format	Scientific Literature
11.	ALA4022850	B	Inhibition of recombinant human alpha-gal A assessed as residual activity at 1 mM using 4 Np-alpha-Gal as substrate by UV-visible spectrophotometric method	Homo sapiens	2		single protein format	Scientific Literature
12.	ALA4022851	B	Inhibition of Alicyclobacillus acidocaldarius beta-galactosidase assessed as residual activity at 1 mM using 2 Np-beta-Gal as substrate by UV-visible spectrophotometric method	Alicyclobacillus acidocaldarius	2		assay format	Scientific Literature
13.	ALA4022852	B	Inhibition of beta-galactosidase derived from human HL60 cells assessed as residual activity at 1 mM using 4-MU-Gal as substrate after 30 mins by fluorescence assay	Homo sapiens	2		assay format	Scientific Literature
14.	ALA4022853	B	Inhibition of Sulfolobus solfataricus alpha fucosidase assessed as residual activity at 1 mM using 4 Np-alpha-Fuc as substrate by UV-visible spectrophotometric method	Saccharolobus solfataricus	2		assay format	Scientific Literature
15.	ALA4022854	B	Inhibition of wild type C57BL/6 mouse small intestinal sucrase/isomaltase using sucrose as substrate after 30 mins	Mus musculus	2		single protein format	Scientific Literature
16.	ALA4022855	B	Inhibition of wild type C57BL/6 mouse small intestinal lactase using lactose as substrate after 30 mins	Mus musculus	1		single protein format	Scientific Literature
17.	ALA4022860	B	Stabilization of recombinant human GAA assessed as increase in melting temperature at 0.1 to 1 mM by SYPRO orange dye-based DSF method	Homo sapiens	1		single protein format	Scientific Literature
18.	ALA4022861	B	Allosteric enhancement of GAA p.L552P/p.L552P mutant activity in pompe disease patient derived fibroblasts at 20 uM using 4-methylunbelliferyl alpha-D-glucopyranoside as substrate preincubated for 4 days followed by substrate addition measured after 60 mins by fluorometric method relative to control	Homo sapiens	2		assay format	Scientific Literature
19.	ALA4022862	B	Allosteric enhancement of GAA p.L552P/p.L552P mutant activity in pompe disease patient derived fibroblasts at 20 uM using 4-methylunbelliferyl alpha-D-glucopyranoside as substrate preincubated for 4 days followed by substrate addition measured after 60 mins in presence of recombinant human GAA by fluorometric method relative to control	Homo sapiens	2		assay format	Scientific Literature
20.	ALA4022863	B	Allosteric enhancement of GAA aberrant splicing/unknown mutant activity in pompe disease patient derived fibroblasts at 20 uM using 4-methylunbelliferyl alpha-D-glucopyranoside as substrate preincubated for 4 days followed by substrate addition measured after 60 mins in presence of recombinant human GAA by fluorometric method	Homo sapiens	2		assay format	Scientific Literature